Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) EBIT (2010 - 2026)

Lite Strategy (LITS) posted EBIT of -$21.6 million for Q1 2026, up 27.65% on a QoQ basis from -$29.9 million in Q4 2025, and down 679.02% year-over-year from $3.7 million in Q1 2025.

Analysis

Lite Strategy (LITS) EBIT (2010 - 2026) Analysis & Trends

Lite Strategy has reported EBIT for 17 years, with the latest figure at -$21.6 million in Q1 2026.

  • On a quarterly basis, EBIT fell 679.02% year-over-year to -$21.6 million in Q1 2026; TTM through Mar 2026 was -$58.1 million, a 73.12% decrease from a year earlier, with the FY2025 full-year figure at -$17.5 million, down 220.03% from the prior year.
  • EBIT was -$21.6 million for Q1 2026 at Lite Strategy, up from -$29.9 million in the prior quarter.
  • The five-year high for EBIT was $55.3 million in Q3 2023, with the low at -$29.9 million in Q4 2025.
  • Average EBIT over 5 years is -$7.8 million, with a median of -$11.1 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2025: EBIT soared 403.42% in 2023, then plunged 765.46% in 2025.
  • Over 5 years, EBIT stood at $8.9 million in 2022, then plunged by 233.65% to -$11.9 million in 2023, then jumped by 71.07% to -$3.5 million in 2024, then slumped by 765.46% to -$29.9 million in 2025, then rose by 27.65% to -$21.6 million in 2026.
  • The last three EBIT figures came in at -$21.6 million (Q1 2026), -$29.9 million (Q4 2025), and -$3.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 493.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -365.99 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - -21.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.61 Mn
Dec 31, 2025 -29.87 Mn
Sep 30, 2025 -3.74 Mn
Jun 30, 2025 -2.88 Mn
Mar 31, 2025 -2.77 Mn
Dec 31, 2024 -3.45 Mn
Sep 30, 2024 -8.35 Mn
Jun 30, 2024 -18.98 Mn
Mar 31, 2024 -9.83 Mn
Dec 31, 2023 -11.93 Mn
Sep 30, 2023 55.28 Mn
Jun 30, 2023 -11.08 Mn
Mar 31, 2023 -16.39 Mn
Dec 31, 2022 8.93 Mn
Sep 30, 2022 -18.22 Mn
Jun 30, 2022 -16.20 Mn
Mar 31, 2022 -21.56 Mn
Dec 31, 2021 -17.63 Mn
Sep 30, 2021 -20.11 Mn
Jun 30, 2021 -15.47 Mn